Epileptic Seizures Treatment Global Market Report 2025
상품코드:1825729
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
간질 발작 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.1%로 45억 9,000만 달러로 성장할 것입니다. 예측 기간의 성장은 정밀의료 접근법, 새로운 치료 방식, 원격의료 및 원격 모니터링, 헬스케어 통합 및 다학제 진료, 규제 지원 및 인센티브에 기인합니다. 예측 기간의 주요 동향으로는 맞춤형 의료, 디지털 헬스 솔루션의 통합, 새로운 치료법, 동반질환과 삶의 질에 대한 강조, 규제 지원 및 시장 접근성 등이 있습니다.
향후 5년간 6.1%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 이스라엘과 프랑스에서 조달하는 항경련제 및 신경자극기 비용을 상승시키고, 발작 통제를 악화시키고, 신경과 지출을 증가시킴으로써 미국을 저해할 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장의 고조와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
간질 발병률의 증가는 향후 간질 발작 치료 시장의 성장을 견인할 것으로 예상됩니다. 간질은 재발성 비유발성 발작이 특징인 신경질환으로 뇌의 비정상적인 전기적 활동으로 인해 경련, 의식상실, 감각장애, 행동장애 등 다양한 증상을 유발하는 질환입니다. 간질 유병률 증가 요인으로는 뇌손상 및 뇌졸중 환자의 생존율 향상, 노인 인구의 증가 등을 들 수 있습니다. 항간질약(AED)을 중심으로 한 효과적인 간질 발작 치료는 발작의 빈도와 중증도를 크게 감소시켜 환자의 일상 생활 기능과 전반적인 웰빙을 보장할 수 있습니다. 예를 들어, 2024년 2월 현재 세계보건기구(WHO)에 따르면 전 세계적으로 약 5,000만 명의 간질 환자가 있으며, 매년 약 500만 명이 새롭게 간질 진단을 받고 있습니다. 따라서 간질 발병률의 증가는 간질 발작 치료 시장의 확대에 박차를 가하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 간질 발작 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 간질 발작 치료 시장 : 성장률 분석
세계의 간질 발작 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 간질 발작 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 간질 발작 치료 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 간질 발작 치료 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
치료 실천
새로운 의약품
개별 요법
세계의 간질 발작 치료 시장 발작 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
부분 발작
전신 발작
분류 불가능 발작
세계의 간질 발작 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구 또는 구강내
비강
직장
비경구
세계의 간질 발작 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 간질 발작 치료 시장 : 하위 세분화 치료법 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
항경련제(AED)
수술
미주신경자극(VNS)
키토제닉 다이어트
반응성 신경자극(RNS)
세계의 간질 발작 치료 시장 : 하위 세분화 새로운 의약품(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
새로운 항경련제
칸나비디올 기반 약물
유전자 치료에 기반한 치료
단클론항체
세계의 간질 발작 치료 시장 : 하위 세분화 개별 요법(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
단독요법
병용요법
보조요법
제7장 지역별·국가별 분석
세계의 간질 발작 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 간질 발작 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
간질 발작 치료 시장 : 경쟁 구도
간질 발작 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Service Inc. Overview, Products and Services, Strategy and Financial Analysis
Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
GlaxoSmithKline plc.
Takeda Pharmaceutical Co. Ltd.
Medtronic plc
GE HealthCare Technologies Inc.
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
UCB S.A.
Eisai Co. Ltd.
Sumitomo Dainippon Pharma Co. Ltd.
Dragerwerk AG & Co.KGaA
H. Lundbeck A/S
Apotex Inc.
Masimo Corporation
Fisher & Paykel Healthcare Limited
Inspiration Healthcare Group Plc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
간질 발작 치료 시장 2029 : 새로운 기회를 제공하는 국가
간질 발작 치료 시장 2029 : 새로운 기회를 제공하는 부문
간질 발작 치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Epileptic seizure treatment encompasses medical interventions and therapies aimed at managing and controlling seizures in individuals with epilepsy, a neurological disorder characterized by recurrent and unpredictable seizures. Treatment options may include medications, lifestyle modifications, dietary therapies, and other interventions tailored to each patient's specific needs, with the goal of reducing seizure frequency and severity and improving overall quality of life.
The main types of epileptic seizure treatment include established treatment practices, emerging drugs, and individualized therapies. Treatment practices involve methodologies used by healthcare professionals to manage symptoms, including pharmacological interventions, surgical procedures, and non-pharmacological therapies. These treatments address various seizure types, such as partial, generalized, and unclassified seizures, and can be administered via oral or buccal, nasal, rectal, or parenteral routes. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The epileptic seizures treatment market research report is one of a series of new reports from The Business Research Company that provides epileptic seizures treatment market statistics, including epileptic seizures treatment industry global market size, regional shares, competitors with an epileptic seizures treatment market share, detailed epileptic seizures treatment market segments, market trends and opportunities, and any further data you may need to thrive in the epileptic seizures treatment industry. This epileptic seizures treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The epileptic seizures treatment market size has grown strongly in recent years. It will grow from $3.42 billion in 2024 to $3.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to advancements in antiepileptic drugs (AEDs), research breakthroughs in epilepsy treatment, increased awareness and education, expanded access to healthcare, and a rise in the prevalence of epilepsy.
The epileptic seizures treatment market size is expected to see strong growth in the next few years. It will grow to $4.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to precision medicine approaches, emerging therapeutic modalities, telemedicine and remote monitoring, healthcare integration and multidisciplinary care, and regulatory support and incentives. Major trends in the forecast period include personalized medicine, integration of digital health solutions, emerging therapeutic modalities, focus on comorbidities and quality of life, and regulatory support and market access.
The forecast of 6.1% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of anti-epileptic drugs and neurostimulation devices sourced from Israel and France, thereby worsening seizure control and elevating neurology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of epilepsy is anticipated to drive the growth of the market for treating epileptic seizures in the future. Epilepsy, a neurological disorder characterized by recurrent, unprovoked seizures, stems from abnormal electrical activity in the brain, leading to various symptoms such as convulsions, loss of consciousness, and sensory or behavioral disturbances. Factors contributing to the rising prevalence of epilepsy include improved survival rates among individuals with brain injuries or strokes and a growing elderly population. Effective treatment of epileptic seizures, primarily through antiepileptic drugs (AEDs), can significantly reduce their frequency and severity, thus ensuring patients' daily functioning and overall well-being. For instance, as of February 2024, the World Health Organization reported approximately 50 million people worldwide suffering from epilepsy, with about 5 million new diagnoses annually. Hence, the increasing incidence of epilepsy is fueling the expansion of the market for treating epileptic seizures.
Key players in the epileptic seizures treatment market are innovating to develop alternative treatment solutions, such as cannabis-based medications, particularly for patients unresponsive to traditional antiseizure drugs. Cannabis-based drugs, derived from the cannabis plant, harness the therapeutic properties of cannabinoids to address various medical conditions, including epilepsy, primarily for their anticonvulsant effects. For example, in January 2024, Akumentis Healthcare Ltd. introduced Clasepi, an orally administered cannabis plant-based medication approved by India's Drug Controller General to manage seizures, especially in children with conditions such as Lennox-Gastaut syndrome, Dravet syndrome, or Tuberous Sclerosis Complex. Clasepi, containing minimal tetrahydrocannabinol (THC) content, has shown efficacy in reducing seizures, particularly in cases where conventional treatments have proven ineffective, albeit it's cautioned for individuals allergic to cannabidiol or its constituents.
In March 2022, UCB SA bolstered its presence in the epileptic seizures treatment market by acquiring Zogenix Inc. for approximately $1.9 billion. This strategic move not only expands UCB's revenue potential but also grants access to promising epilepsy treatments, reinforcing its commitment to offering innovative solutions for severe forms of epilepsy such as Dravet syndrome. Zogenix Inc., a US-based biopharmaceutical company specializing in drugs and therapies for rare diseases, particularly rare pediatric epilepsy, thus enhances UCB's portfolio and strengthens its position in addressing the unmet medical needs of epilepsy patients.
Major companies operating in the epileptic seizures treatment market are Pfizer Inc., Johnson & Johnson Service Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Takeda Pharmaceutical Co. Ltd., Medtronic plc, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Dragerwerk AG & Co.KGaA, H. Lundbeck A/S, Apotex Inc., Masimo Corporation, Fisher & Paykel Healthcare Limited, Inspiration Healthcare Group Plc., Phoenix Medical Systems (P) Ltd., Marinus Pharmaceuticals Inc., Alexza Pharmaceuticals Inc., Neurelis Inc., Veriton Pharma
North America was the largest region in the epileptic seizures treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epileptic seizures treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the epileptic seizures treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The epileptic seizures treatment market consists of revenues earned by entities by providing services, such as medication management, rehabilitation services, diagnostic services, telemedicine, and remote monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The epileptic seizures treatment market also includes sales of anti-epileptic drugs, surgical implants, ketogenic diet products, seizure alarms, and vagus nerve stimulators which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Epileptic Seizures Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on epileptic seizures treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for epileptic seizures treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The epileptic seizures treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Treatment Practices; Emerging Drugs; Individual Therapies
2) By Seizure Type: Partial Seizures; Generalized Seizures; Unclassified Seizures
3) By Route of Administration: Oral Or Buccal; Nasal; Rectal; Parenteral
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3. Epileptic Seizures Treatment Market Trends And Strategies
4. Epileptic Seizures Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Epileptic Seizures Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Epileptic Seizures Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Epileptic Seizures Treatment Market Growth Rate Analysis
5.4. Global Epileptic Seizures Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Epileptic Seizures Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Epileptic Seizures Treatment Total Addressable Market (TAM)
6.1. Global Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Treatment Practices
Emerging Drugs
Individual Therapies
6.2. Global Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Partial Seizures
Generalized Seizures
Unclassified Seizures
6.3. Global Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Or Buccal
Nasal
Rectal
Parenteral
6.4. Global Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Treatment Practices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antiepileptic Drugs (AEDs)
Surgery
Vagus Nerve Stimulation (VNS)
Ketogenic Diet
Responsive Neurostimulation (RNS)
6.6. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Emerging Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
New Antiepileptic Medications
Cannabidiol-based Drugs
Gene Therapy-Based Treatments
Monoclonal Antibodies
6.7. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Individual Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monotherapy
Combination Therapy
Adjunctive Therapy
7. Epileptic Seizures Treatment Market Regional And Country Analysis
7.1. Global Epileptic Seizures Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Epileptic Seizures Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Epileptic Seizures Treatment Market
9.1. China Epileptic Seizures Treatment Market Overview
9.2. China Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Epileptic Seizures Treatment Market
10.1. India Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Epileptic Seizures Treatment Market
11.1. Japan Epileptic Seizures Treatment Market Overview
11.2. Japan Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Epileptic Seizures Treatment Market
12.1. Australia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Epileptic Seizures Treatment Market
13.1. Indonesia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Epileptic Seizures Treatment Market
14.1. South Korea Epileptic Seizures Treatment Market Overview
14.2. South Korea Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Epileptic Seizures Treatment Market
15.1. Western Europe Epileptic Seizures Treatment Market Overview
15.2. Western Europe Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Epileptic Seizures Treatment Market
16.1. UK Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Epileptic Seizures Treatment Market
17.1. Germany Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Epileptic Seizures Treatment Market
18.1. France Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Epileptic Seizures Treatment Market
19.1. Italy Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Epileptic Seizures Treatment Market
20.1. Spain Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Epileptic Seizures Treatment Market
21.1. Eastern Europe Epileptic Seizures Treatment Market Overview
21.2. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Epileptic Seizures Treatment Market
22.1. Russia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Epileptic Seizures Treatment Market
23.1. North America Epileptic Seizures Treatment Market Overview
23.2. North America Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Epileptic Seizures Treatment Market
24.1. USA Epileptic Seizures Treatment Market Overview
24.2. USA Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Epileptic Seizures Treatment Market
26.1. South America Epileptic Seizures Treatment Market Overview
26.2. South America Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Epileptic Seizures Treatment Market
27.1. Brazil Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Epileptic Seizures Treatment Market
28.1. Middle East Epileptic Seizures Treatment Market Overview
28.2. Middle East Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Epileptic Seizures Treatment Market
29.1. Africa Epileptic Seizures Treatment Market Overview
29.2. Africa Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Epileptic Seizures Treatment Market Competitive Landscape And Company Profiles
